sub:assertion {
  d:DB00285 v:identifier "DB00285" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB00285" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB00285> ;
    dv:drugbank-id "APRD00125" , "DB00285" ;
    dv:x-ahfs <http://bio2rdf.org/ahfs:28:16.04.92> ;
    dv:x-atc <http://bio2rdf.org/atc:N06AX16> ;
    dv:x-cas <http://bio2rdf.org/cas:93413-69-5> ;
    dv:x-chebi <http://bio2rdf.org/chebi:9943> ;
    dv:x-chemspider <http://bio2rdf.org/chemspider:5454> ;
    dv:x-dpd <http://bio2rdf.org/dpd:2237279> ;
    dv:x-kegg <http://bio2rdf.org/kegg:C07187> , <http://bio2rdf.org/kegg:D08670> ;
    dv:x-ndc <http://bio2rdf.org/ndc:0378-4881-01> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA451866> ;
    dv:x-pubchemcompound <http://bio2rdf.org/pubchem.compound:5656> ;
    dv:x-pubchemsubstance <http://bio2rdf.org/pubchem.substance:46504593> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:Venlafaxine> ;
    dct:description "Venlafaxine (Effexor) is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class first introduced by Wyeth in 1993. It is prescribed for the treatment of clinical depression and anxiety disorders. Due to the pronounced side effects and suspicions that venlafaxine may significantly increase the risk of suicide it is not recommended as a first line treatment of depression. However, it is often effective for depression not responding to SSRIs. Venlafaxine was the sixth most widely-used antidepressant based on the amount of retail prescriptions in the US (17.1 million) in 2006. [Wikipedia]"@en ;
    dct:identifier "drugbank:DB00285" ;
    dct:title "Venlafaxine"@en ;
    a dv:Drug ;
    rdfs:label "Venlafaxine [drugbank:DB00285]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB00285> , <http://www.drugs.com/venlafaxine.html> , <http://www.pdrhealth.com/drugs/rx/rx-mono.aspx?contentFileName=eff1794.html&contentName=Effexor%20XR&contentId=277> , <http://www.rxlist.com/cgi/generic/venlafax.htm> .
}